Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-18

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Oxymorphone hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the marketing of a generic opioid analgesic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)